These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15102364)

  • 21. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 22. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
    Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
    J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular Mimicry and Guillain-Barré Syndrome].
    Yuki N
    Brain Nerve; 2015 Nov; 67(11):1341-6. PubMed ID: 26560949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guillain-Barré Syndrome and its association with infectious factors].
    Grygorczuk S; Zajkowska J; Kondrusik M; Pancewicz S; Hermanowska-Szpakowicz T
    Neurol Neurochir Pol; 2005; 39(3):230-6. PubMed ID: 15981163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and pathogeneses of Guillain-Barré syndrome and related diseases: focusing on anti-gangliosides antibody].
    Uchibori A; Chiba A
    No To Shinkei; 2005 Feb; 57(2):97-106. PubMed ID: 15856755
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guillain-Barré syndrome: immunopathology, update].
    Chiba A
    Nihon Rinsho; 2008 Jun; 66(6):1184-9. PubMed ID: 18540368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome: expanding the concept of molecular mimicry.
    Laman JD; Huizinga R; Boons GJ; Jacobs BC
    Trends Immunol; 2022 Apr; 43(4):296-308. PubMed ID: 35256276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
    Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
    Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndrome.
    Wokke JH; van den Berg LH
    Neurology; 2005 Nov; 65(9):1350-1. PubMed ID: 16275819
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome.
    Schwerer B
    Microbes Infect; 2002 Mar; 4(3):373-84. PubMed ID: 11909748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sialosyl-galactose: a common denominator of Guillain-Barré and related disorders?
    Moran AP; Prendergast MM; Hogan EL
    J Neurol Sci; 2002 Apr; 196(1-2):1-7. PubMed ID: 11959149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.
    Yu RK; Usuki S; Ariga T
    Infect Immun; 2006 Dec; 74(12):6517-27. PubMed ID: 16966405
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barré syndrome: update on immunobiology and treatment.
    Kaida K; Kusunoki S
    Expert Rev Neurother; 2009 Sep; 9(9):1307-19. PubMed ID: 19769446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barre syndrome: first description of a snake envenomation aetiology.
    Neil J; Choumet V; Le Coupanec A; d'Alayer J; Demeret S; Musset L
    J Neuroimmunol; 2012 Jan; 242(1-2):72-7. PubMed ID: 22172144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatments.
    Toyka KV
    Rev Neurol (Paris); 1999 Oct; 155(10):849-56. PubMed ID: 10546299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
    Ang CW; Tio-Gillen AP; Groen J; Herbrink P; Jacobs BC; Van Koningsveld R; Osterhaus AD; Van der Meché FG; van Doorn PA
    J Neuroimmunol; 2002 Sep; 130(1-2):179-83. PubMed ID: 12225900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acquired demyelinating neuropathies].
    Hahn AF
    Rev Prat; 2000 Apr; 50(7):724-30. PubMed ID: 10853551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.